Love stories from listeners of Barangay LSFM are featured in this weekly radio program. Listen in as Papa Dudut reads the letter of a "kabarangay" who shares his/her heartfelt experience. A dramatization brings the audience closer to feeling the joy, the pain, the ups and downs of being in love--something that each one of us can relate to.
…
continue reading
Content provided by The Mark White Show and Mark White. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Mark White Show and Mark White or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!
Go offline with the Player FM app!
Dr. Rakesh Jain & Sherland Peterson Discuss Tardive Dyskinesia
MP3•Episode home
Manage episode 430312209 series 2396401
Content provided by The Mark White Show and Mark White. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Mark White Show and Mark White or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Currently, more than 14 million Americans have a serious mental illness, such as bipolar disorder, major depressive disorder and schizophrenia, conditions that can be treated with antipsychotic medicines. Use of these medicines has increased 22%, increasing the risk for developing a debilitating chronic movement condition called tardive dyskinesia. Tardive dyskinesia can cause debilitating uncontrollable and repetitive movements that can make eating, drinking and walking difficult. While tardive dyskinesia can be treated, integrating new medicines into any existing treatment plan can be challenging. Sometimes regimens can become complex causing patients to feel overwhelmed and give up on treatment or go without treatment entirely. The U.S. Food and Drug Administration has approved a new treatment formulation – one pill, taken once-daily – that could help the millions of Americans living with a serious mental illness whose antipsychotic medications may cause this condition. This new formulation of an established treatment can be integrated into existing mental health treatment plans. On tonight’s show, Rakesh Jain, MD, MPH, Clinical Professor, Department of Psychiatry, Texas Tech University School of Medicine is joining me to discuss tardive dyskinesia, its impact on peoples’ lives and the importance of this treatment formulation and Sherland Peterson is sharing her experience with TD, and how it has impacted her quality of life.
…
continue reading
3189 episodes
MP3•Episode home
Manage episode 430312209 series 2396401
Content provided by The Mark White Show and Mark White. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Mark White Show and Mark White or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Currently, more than 14 million Americans have a serious mental illness, such as bipolar disorder, major depressive disorder and schizophrenia, conditions that can be treated with antipsychotic medicines. Use of these medicines has increased 22%, increasing the risk for developing a debilitating chronic movement condition called tardive dyskinesia. Tardive dyskinesia can cause debilitating uncontrollable and repetitive movements that can make eating, drinking and walking difficult. While tardive dyskinesia can be treated, integrating new medicines into any existing treatment plan can be challenging. Sometimes regimens can become complex causing patients to feel overwhelmed and give up on treatment or go without treatment entirely. The U.S. Food and Drug Administration has approved a new treatment formulation – one pill, taken once-daily – that could help the millions of Americans living with a serious mental illness whose antipsychotic medications may cause this condition. This new formulation of an established treatment can be integrated into existing mental health treatment plans. On tonight’s show, Rakesh Jain, MD, MPH, Clinical Professor, Department of Psychiatry, Texas Tech University School of Medicine is joining me to discuss tardive dyskinesia, its impact on peoples’ lives and the importance of this treatment formulation and Sherland Peterson is sharing her experience with TD, and how it has impacted her quality of life.
…
continue reading
3189 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.